期刊文献+

辛伐他汀对人脐静脉血晚期内皮祖细胞数量和功能的影响

Effect of simvastatin on the quantity and function of human umbilical cord blood-derived late endothelial progenitor cells
原文传递
导出
摘要 目的:研究不同浓度辛伐他汀对体外培养的人脐静脉血晚期内皮祖细胞(EPCs)数量和功能的影响。方法:用密度梯度离心法分离人脐静脉血单个核细胞,接种于人纤维连接蛋白包被的培养瓶,在EGM-2MV培养基中诱导分化获得晚期EPCs,并通过流式细胞术及免疫荧光染色进行鉴定。取生长状态良好的第2代晚期EPCs与不同浓度辛伐他汀(10-8、10-7、10-6及10-5mol/L)培养24、48及72h后,采用CCK-8增殖能力检测、粘附能力测定及血管形成实验来观察辛伐他汀对晚期EPCs增殖、粘附及血管形成能力的影响。结果:从人脐静脉血中成功分离并培养出晚期EPCs。与对照组相比,较低浓度辛伐他汀(10-8、10-7与10-6mol/L)对晚期EPCs的增殖、粘附及血管形成有明显促进作用,以10-7mol/L组作用最强;高浓度(10-5mol/L)则抑制EPCs的上述功能。辛伐他汀促增殖作用随时间延长而增加,而粘附与体外血管形成能力则在48h作用最强。结论:辛伐他汀在较低浓度时显著增加了晚期EPCs的数量并改善其功能,高浓度则起抑制作用。 Objective:To investigate the effect of simvastatin on the quantity and function of late endothelial progenitor cells(EPCs)from human umbilical cord blood in vitro.Method:Mononuclear cells were isolated from human umbilical cord blood by density gradient centrifugation and cultured on fibronectin-coated culture flask, then the cells cultured in EGM-2MV medium differentiated into late EPCs which were identified by flow cytometry and fluorescent staining.The good growth state of late EPCs of second generation were treated with simvastatin in a series of concentrations(10-8,10-7,10-6,10-5 mol/L)for 24,48,72hand the proliferation,adhesion and tubule-formation activity of EPCs were analyzed by CCK-8reagent kit,adhesive assay and tubule-formation assay respectively.Result:Late EPCs were isolated and cultured successfully from human umbilical cord blood.Com- pared with control group,lower concentrations of simvastatin(10-8,10-7,10-6 mol/L)significantly promoted cell proliferation,adhesion and in vitro vascularization and the concentration of 10-7 mol/L was the most prominent,while higher concentration(1 0-5 mol/L)inhibited the functions above.Simvastatin increased the proliferative capacity of EPCs in a time dependent manner,but adhesion and tubule-formation activity were the most prominent at 48h.Conclusion:Simvastatin enhances the count of late EPCs and improve cell functions remarkably at lower concentrations,while higher concentration elicit inhibitory effects.
出处 《临床心血管病杂志》 CAS CSCD 北大核心 2013年第6期470-474,共5页 Journal of Clinical Cardiology
基金 广东省科技计划项目(No:2010-1096-136) 广州市科技计划项目(No:2010Y1-C941) 暨南大学第一临床医学院重点学科基金项目(No:2010-4)
关键词 晚期内皮祖细胞 辛伐他汀 增殖 黏附 血管形成 late endothelial progenitor cells simvastatin proliferation adhesion tubule-formation
  • 相关文献

参考文献14

  • 1LI D W,LIU Z Q,WEI J,et al.Contribution of en-dothelial progenitor cells to neovascularization[J].Int J Mol Med,2012,30:1000-1006.
  • 2HUR J,YOON C H,KIM H S,et al.Characteriza-tion of two types of endothelial progenitor cells and their different contributions to neovasculogenesis[J].Arterioscler Thromb Vasc Biol,2004,24:288-293.
  • 3CHENG Y,HU R Y,LV L,et al.Erythropoietin improves the efficiency of endothelial progenitor cell therapy after myocardial infarction in mice:effects on transplanted cell survival and autologous endothelial progenitor cell mobilization[J].J Surg Res,2012,176:E47-E55.
  • 4MOUBARIK C,GUILLET B,YOUSSEF B,et al.Transplanted late outgrowth endothelial progenitor cells as cell therapy product for stroke[J].Stem Cell Rev Rep,2011,7:208-220.
  • 5ZHOU Q,LIAO J K.Pleiotropic effects of statins[J].Circ J,2010,74:818-826.
  • 6INGRAM D A,MEAD L E,TANAKA H,et al.I-dentification of a novel hierarchy of endothelial pro-genitor cells using human peripheral and umbilical cord blood[J].Blood,2004,104:2752-2760.
  • 7BRIGUORI C,TESTA U,RICCIONI R,et al.Cor-relations between progression of coronary artery dis-ease and circulating endothelial progenitor cells[J].FASEB J,2010,24:1981-1988.
  • 8YODER M C.Human endothelial progenitor cells[J].Cold Spring Harb Perspect Med,2012,2:1-14.
  • 9THAVENDIRANATHAN P,BAGAI A,BROOKHART M A,et al.Primary prevention of cardiovascular diseases with statin therapy:A meta-analysis of randomized con-trolled trials[J].Arch Intern Med,2006,166:2307-2313.
  • 10马骏,姜萌,何奔.他汀类药物对内皮祖细胞的相关作用[J].中国组织工程研究与临床康复,2011,15(6):1115-1118. 被引量:2

二级参考文献25

  • 1Rosenzweig A. Endothelial progenitor cekks[J]. N Engel J Med, 2003,348(7): 581-582.
  • 2Vaikoczy P,Blum S, Lamparter M, et al. Multistep nature of microvascular recruitment of ex vivo-expanded embryonic endothelial progenitor cells during tumor angiogenesis[J]. J Exp Med,2003,197(12) : 1755-1765.
  • 3Schonbeck U, Libby P. Inflammation, immunity, and HMGCoA reductase inhibitors: statins as antiinflammatory agents [J].? Circulation, 2004,109(21) : 18-26.
  • 4John S, Schneider MP, Delles C, et al. Lipid-independent effects of statins on endothelial function and bioavailability of nitric oxide in hypercholesterolemic patients[J]. Am Heart J, 2005,149(3):473-474.
  • 5Ali F, Hamdulay SS, Kinderlerer AR, et al. Statin-mediated cytop roteetion of human vascular endothelial cells: a role for Kruppel2 like factor 22-dependent induction of heme oxygenasel[J]. J Thromb Haemost, 2007,5 (12): 2537-2546.
  • 6Cirillo P, Pacileo M, de Rosa S,et al. HMG2CoA reductase inhibitors reduce nicotine-induced expression of cellular adhesion molecules in cultured human coronary endothelial cells [J]. J Vasc Res,2007,44(6):460-470.
  • 7Asahara T, Murohara T, Sullivan A, et al. Isolation of putative endothelial progenitor cells for angiogenesis. Science, 1997, 275: 964-967.
  • 8Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood, 2000, 95: 952-958.
  • 9Asahara T, Masuda H, Takahashi T, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res, 1999, 85: 221-228.
  • 10Kocher AA, Schuster MD, Szabolcs MJ, et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med, 2001, 7: 430-436.

共引文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部